Table 1 The relationship between patients’ characteristics and chemotherapy regimens
Variables | N | Gemcitabine | Docetaxel | P |
|---|---|---|---|---|
Gender | ||||
Female | 28 | 15(53.6) | 13(46.4) | 0.843 |
Male | 300 | 169(56.3) | 131(43.7) | |
Age | ||||
<65 | 210 | 112(53.3) | 98(46.7) | 0.203 |
≥ 65 | 118 | 72(61.0) | 46(39.0) | |
Tumor location | ||||
Left | 145 | 85(58.6) | 60(41.4) | 0.434 |
Right | 183 | 99(54.1) | 84(45.9) | |
Histology | ||||
SCC | 242 | 140(57.9) | 102(42.1) | 0.482 |
Ade | 59 | 29(49.2) | 30(50.8) | |
Others | 27 | 15(55.6) | 12(44.4) | |
Concurrent CRT | ||||
Yes | 253 | 146(57.7) | 107(42.3) | 0.281 |
No | 75 | 38(50.7) | 37(49.3) | |
T stage | ||||
T1–2 | 187 | 107(57.2) | 80(42.8) | 0.637 |
T3–4 | 141 | 77(54.6) | 64(45.4) | |
N stage | ||||
N0–1 | 64 | 42(65.6) | 22(34.4) | 0.087 |
N2–3 | 264 | 142(53.8) | 122(46.2) | |
PTV volume | ||||
≤ 330 cc | 164 | 95(57.9) | 69(42.1) | 0.504 |
>330 cc | 164 | 89(54.3) | 75(45.7) | |
Lung volume | ||||
≤ 3248 cc | 177 | 101(57.1) | 76(42.9) | 0.703 |
>3248 cc | 151 | 83(55.0) | 68(45.0) | |
V5 | ||||
≤ 44 | 160 | 95 (59.4) | 65 (40.6) | 0.243 |
>44 | 168 | 89 (53.0) | 79 (47.0) | |
V20 | ||||
≤ 24 | 187 | 114 (61.0) | 73 (39.0) | 0.041 |
>24 | 141 | 70 (49.6) | 71 (50.4) | |
V30 | ||||
≤ 14.2 | 122 | 71 (57.4) | 52 (42.6) | 0.691 |
>14.2 | 205 | 113 (55.1) | 92 (44.9) | |
MLD | ||||
≤ 1226 cGy | 164 | 106 (64.6) | 58 (35.4) | 0.002 |
>1266 cGy | 164 | 78 (47.6) | 86 (52.4) | |
RP | ||||
1 | 262 | 137(52.3) | 125(47.7) | 0.006 |
2 | 49 | 32(65.3) | 17(34.7) | |
3–4 | 17 | 15(88.2) | 2(11.8) | |